Response of the damaged dopamine system to gm1 and semisynthetic gangliosides: Effects of dose and extent of lesion

This publication has 20 references indexed in Scilit:

• Oral administration of semisynthetic sphingolipids promotes recovery of striatal dopamine concentrations in a murine model of parkinsonism
  Neurology, 1994
• LIGA 20 increases striatal dopamine levels in aged MPTP-treated mice refractory to GM1 ganglioside treatment
  NeuroReport, 1993
• Molecular parameters of semisynthetic derivatives of gangliosides and sphingosine in monolayers at the air-water interface
  Chemistry and Physics of Lipids, 1993
• GM1 Ganglioside Therapy in Acute Ischemic Stroke
  Cerebrovascular Diseases, 1992
• Recovery of Motor Function after Spinal-Cord Injury — A Randomized, Placebo-Controlled Trial with GM-1 Ganglioside
  New England Journal of Medicine, 1991
• Monosialoganglioside in subarachnoid hemorrhage.
  Stroke, 1991
• Glycosphingolipids that Can Regulate Nerve Growth and Repair
  Published by Elsevier ,1990
• Uptake, cell penetration and metabolic processing of exogenously administered GM1 ganglioside in rat brain
  Neurochemistry International, 1989
• Administration of GMI. ganglioside restores the dopamine content in striatum after chronic treatment with MPTP
  Neuropharmacology, 1986
• Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting*
  Acta Physiologica Scandinavica, 1983